C1027 chromophore, a potent new enediyne antitumor antibiotic, induces sequence-specific double-strand DNA cleavage.
暂无分享,去创建一个
[1] O. Hensens,et al. Spontaneous generation of a biradical species of neocarzinostatin chromophore: role in DNA bulge-specific cleavage. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[2] I. Goldberg,et al. Site-specific cleavage at a DNA bulge by neocarzinostatin chromophore via a novel mechanism. , 1993, Biochemistry.
[3] I. Goldberg,et al. DNA conformation-induced activation of an enediyne for site-specific cleavage. , 1993, Science.
[4] Stella Huang,et al. Chemistry and structure elucidation of the kedarcidin chromophore , 1993 .
[5] T. Ishii,et al. Synthesis and absolute stereochemistry of the aminosugar moiety of antibiotic C-1027 chromophore , 1993 .
[6] Y. Sugiura,et al. Some characteristics of DNA strand scission by macromolecular antitumor antibiotic C-1027 containing a novel enediyne chromophore. , 1993, Biochemistry.
[7] T. Otani. Conformation studies on and assessment by spectral analysis of the protein-chromophore interaction of the macromolecular antitumor antibiotic C-1027. , 1993, The Journal of antibiotics.
[8] Ken‐ichiro Yoshida,et al. Structure of an aromatization product of C-1027 chromophore , 1993 .
[9] T. Tullius,et al. How the structure of an adenine tract depends on sequence context: a new model for the structure of TnAn DNA sequences. , 1993, Biochemistry.
[10] C. Townsend,et al. Specific abstraction of the 5'S- and 4'-deoxyribosyl hydrogen atoms from DNA by calicheamicin .gamma.1I , 1992 .
[11] I. Goldberg,et al. Neocarzinostatin acts as a sensitive probe of DNA microheterogeneity: switching of chemistry from C-1' to C-4' by a G.T mismatch 5' to the site of DNA damage. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] P. Dedon,et al. Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin, and calicheamicin. , 1992, Chemical research in toxicology.
[13] P. Dedon,et al. Neocarzinostatin-mediated DNA damage in a model AGT.ACT site: mechanistic studies of thiol-sensitive partitioning of C4' DNA damage products. , 1992, Biochemistry.
[14] M. Lee,et al. Calicheamicins: Discovery, Structure, Chemistry, and Interaction with DNA , 1991 .
[15] I. Goldberg. Mechanism of Neocarzinostatin Action: Role of DNA Microstructure in Determination of Chemistry of Bistranded Oxidative Damage , 1991 .
[16] T. Otani,et al. Isolation and characterization of non-protein chromophore and its degradation product from antibiotic C-1027. , 1991, The Journal of antibiotics.
[17] S. Meschwitz,et al. Selective abstraction of 2H from C-5' of thymidylate in an oligodeoxynucleotide by the radical center at C-6 of the diradical species of neocarzinostatin: chemical evidence for the structure of the activated drug-DNA complex. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[18] P. Dedon,et al. Sequence-specific double-strand breakage of DNA by neocarzinostatin involves different chemical mechanisms within a staggered cleavage site. , 1990, The Journal of biological chemistry.
[19] Y. Sugiura,et al. DNA intercalation and cleavage of an antitumor antibiotic dynemicin that contains anthracycline and enediyne cores. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[20] Y. Sugimoto,et al. Mechanism of action of a new macromolecular antitumor antibiotic, C-1027. , 1990, The Journal of antibiotics.
[21] D. Vanderwall,et al. Sequence-specific isotope effects on the cleavage of DNA by bleomycin. , 1989, Science.
[22] H. Saito,et al. A new macromolecular antitumor antibiotic, C-1027. III. Antitumor activity. , 1989, The Journal of antibiotics.
[23] Y. Yamada,et al. A new macromolecular antitumor antibiotic, C-1027. I. Discovery, taxonomy of producing organism, fermentation and biological activity. , 1988, The Journal of antibiotics.
[24] T. Otani,et al. A new macromolecular antitumor antibiotic, C-1027. II. Isolation and physico-chemical properties. , 1988, The Journal of antibiotics.
[25] G. Ellestad,et al. Calicheamicin gamma 1I: an antitumor antibiotic that cleaves double-stranded DNA site specifically. , 1988, Science.
[26] L. Povirk,et al. Effect of apurinic/apyrimidinic endonucleases and polyamines on DNA treated with bleomycin and neocarzinostatin: specific formation and cleavage of closely opposed lesions in complementary strands. , 1988, Biochemistry.
[27] J. Stubbe,et al. Mechanisms of bleomycin-induced DNA degradation , 1987 .
[28] I. Goldberg,et al. Deoxyribonucleic acid damage by neocarzinostatin chromophore: strand breaks generated by selective oxidation of C-5' of deoxyribose. , 1983, Biochemistry.
[29] C. Iden,et al. Bleomycin-induced strand-scission of DNA. Mechanism of deoxyribose cleavage. , 1981, The Journal of biological chemistry.
[30] T. Hatayama,et al. DNA damage and repair in relation to cell killing in neocarzinostatin-treated HeLa cells. , 1979, Biochimica et biophysica acta.
[31] R. Lloyd,et al. Bleomycin-specific fragmentation of double-stranded DNA. , 1978, Biochemistry.
[32] L. Povirk,et al. DNA double-strand breaks and alkali-labile bonds produced by bleomycin. , 1977, Nucleic acids research.
[33] S. Schreiber,et al. Site-specific atom transfer from DNA to a bound ligand defines the geometry of a DNA-calicheamicin .gamma.1I complex , 1990 .
[34] J. Catino,et al. Esperamicins, a class of potent antitumor antibiotics: mechanism of action. , 1989, Proceedings of the National Academy of Sciences of the United States of America.